Newstin - NicOx

NicOx signs extension of ophthalmology agreement with Pfizer (Marketwire)

Wed, 01 Oct 2008 11:31:07 GMT

Tuesday January 8, 2008 1:06 am ET SOPHIA ANTIPOLIS, FRANCE--(MARKET WIRE)--Jan 8, 2008 -- Sophia Antipolis, France. www.nicox.com NicOx S.A. (Euronext Paris: COX) today announced it has signed an extension of its March 2006...

NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules

Tue, 23 Sep 2008 11:00:00 GMT

NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules SOPHIA ANTIPOLIS, France, September 23 /PRNewswire-FirstCall/ -- NicOx recently announced the results of the second pivotal...

NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints...

Tue, 16 Sep 2008 08:50:28 GMT

PARIS, September 15, 2008 /PRNewswire-FirstCall/ -- NicOx S.A. today announced successful top-line results from the second phase 3 study for naproxcinod in 1020 patients with osteoarthritis of the knee (the 302 study)....

NicOx Provides Update on PF-03187207 and the Ongoing Research Collaboration with Pfizer

Thu, 28 Aug 2008 09:55:56 GMT

SOPHIA ANTIPOLIS, France, August 25, 2008 -NicOx S.A. (Euronext Paris: COX) today announced the results of a dose-ranging phase 2 study conducted with PF-03187207 in Japanese patients with glaucoma by its partner Pfizer...

BORSE EUROPA: Indici in netto calo, in controtendenza Fiat e RHEINMETALL

Wed, 27 Aug 2008 08:23:39 GMT

Le piazze europee sono in calo, non si lasciano impressionare dal balzo in avanti Nikkei, al massimo di due settimane, e dall’andamento positivo delle altre borse asiatiche. In positivo invece l’indice che raggruppa i...

NicOx Says Pfizer Has Abandoned Plans To Launch Glaucoma Drug Study In Asia

Mon, 25 Aug 2008 06:49:46 GMT

Monday, French biotechnology firm NicOx S.A. (COX.PA) said that a phase II Japanese study of glaucoma drug PF-03187207 did not meet its primary end point of reduction in intraocular pressure at day 28. The company also...

Nicox says Pfizer drops glaucoma drug study in Asia

Mon, 25 Aug 2008 08:40:00 GMT

PARIS (Reuters) - French biotechnology firm Nicox said on Monday U.S. partner Pfizer had decided not to launch Phase III studies in Asia of an experimental treatment of glaucoma and ocular hypertension....

Paris shares lower, tracking Wall St; EADS, financial, auto stocks fall UPDATE

Mon, 28 Jul 2008 16:50:27 GMT

PARIS (Thomson Financial) - Financial and auto stocks weighed on trading, following negative notes from Citigroup, while EADS ended down sharply after saying it continues to face challenges with its A400M and A380 aircraft. The...

First Half 2008 Financial Results: NicOx Nears Completion of Phase 3 Naproxcinod Studies

Mon, 28 Jul 2008 11:00:00 GMT

First Half 2008 Financial Results: NicOx Nears Completion of Phase 3 Naproxcinod Studies SOPHIA ANTIPOLIS, France, July 28 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today reported its financial results for the...

Nicox H1 net loss widens sharply as sales decline and operating expenses rise

Mon, 28 Jul 2008 06:21:13 GMT

PARIS (Thomson Financial) - French pharmaceuticals group Nicox SA posted a net loss of 33.1 million euros for the first six months of 2008, compared to a net loss of 6.6 million a year as operating expenses grew and sales fell....